PFIZER INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer
- Conditions
- Lung Neoplasms
- First Posted Date
- 2004-09-06
- Last Posted Date
- 2012-05-10
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00090701
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, New York, New York, United States
A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration
- Conditions
- Age-Related Macular Degeneration
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2011-05-27
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 155
- Registration Number
- NCT00090532
- Locations
- ๐ฌ๐ง
Pfizer Investigational Site, London, United Kingdom
CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse
- Conditions
- Leukemia
- First Posted Date
- 2004-08-24
- Last Posted Date
- 2012-08-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 55
- Registration Number
- NCT00003131
- Locations
- ๐บ๐ธ
Sylvester Cancer Center, University of Miami, Miami, Florida, United States
๐บ๐ธBeckman Research Institute, City of Hope, Duarte, California, United States
๐บ๐ธMarlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma
- First Posted Date
- 2004-08-11
- Last Posted Date
- 2010-01-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 61
- Registration Number
- NCT00089648
- Locations
- ๐บ๐ธ
Pfizer Investigational Site, Dallas, Texas, United States
Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2012-08-08
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00004199
- Locations
- ๐บ๐ธ
Agouron Pharmaceuticals, Inc., La Jolla, California, United States
Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2012-08-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 525
- Registration Number
- NCT00003343
- Locations
- ๐บ๐ธ
Agouron Pharmaceuticals, Inc., La Jolla, California, United States
Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Conditions
- Skin/Soft Tissue InfectionsMethicillin Resistant Staphylococcus Aureus (MRSA)
- First Posted Date
- 2004-07-13
- Last Posted Date
- 2012-08-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1077
- Registration Number
- NCT00087490
- Locations
- ๐ป๐ช
Pfizer Investigational Site, Valencia, Venezuela
Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy
- Conditions
- Stomach Neoplasms
- First Posted Date
- 2004-07-13
- Last Posted Date
- 2008-04-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 28
- Registration Number
- NCT00087503
- Locations
Pfizer Investigational Site
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-06-18
- Last Posted Date
- 2012-08-10
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00005093
- Locations
- ๐บ๐ธ
New England Medical Center Hospital, Boston, Massachusetts, United States
๐จ๐ฆBC Cancer Agency, Vancouver, British Columbia, Canada
๐บ๐ธUniversity of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2004-06-18
- Last Posted Date
- 2012-08-10
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00004861
- Locations
- ๐บ๐ธ
Cedars-Sinai Comprehensive Cancer Center, Los Angeles, California, United States
๐บ๐ธIreland Cancer Center, Cleveland, Ohio, United States
๐บ๐ธSinai Hospital of Baltimore, Baltimore, Maryland, United States